Voyager Therapeutics, Inc. Annual Income Tax Expense (Benefit) in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Voyager Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2015 to 2023.
  • Voyager Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $24K, a 59.3% decline year-over-year.
  • Voyager Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $683K.
  • Voyager Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $1.41M, a 8700% increase from 2022.
  • Voyager Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $16K.
  • Voyager Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2018 was -$180K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.41M +$1.39M +8700% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $16K Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2018 -$180K Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2016 $52K +$52K Jan 1, 2016 Dec 31, 2016 10-K 2019-02-26
2015 $0 Jan 1, 2015 Dec 31, 2015 10-K 2017-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.